www.eclobeauty.com

Beauty Supplements Are the Fastest-Growing Category in Consumer Health.
Europe is still waiting for its clean beauty leader.

ECLO BEAUTY — APRIL 2026 — CONFIDENTIAL

01 — ECLO TODAY

Eclo Today

33.6K
Instagram followers
Organic
16K+
Active Klaviyo subscribers
35%+ open rate
~100
Retail stores in France
Inbound B2B requests
30%
Revenue from repeat customers
High for makeup-skincare
10K+
DTC customers who trust us
4.81/5
Product rating — 86% at 5 stars
150+
Press & influencer features
ELLE Vogue Marie Claire Le Monde L'Obs Biba
02 — IN NUMBERS

~€50K/month turnover. 51% recurring.

Q1 23 Q1 24 Q1 25 Q1 26 €8K €80K
Quarterly recurring revenue · +934% in 3 years · from 15% to 51%
RECURRING REVENUE
€27K/mo
● ~€10K BtC
● €15–20K B2B
74%
B2B margin
3.24×
Ad ROI · spend -35%
STOCK VALUE
€250K
At cost — worth €1M+ retail. Covers 6+ months.
CASH POSITION
Controlled
Reduced burn. Fixed costs <€20K/mo. Lean team (4).
NEXT LAUNCHES
May 26 · Regenerating Hand Balm
June 26 · Eye Patches
July 26 · Supplements (5 SKUs)
03 — PRODUCT LAUNCHES

100% success rate on recent product launches.

A successful repositioning towards clean skincare and a refocus of makeup towards higher-repeat, higher-margin products.

Soin Concentré
Launched Sept 2025 · Skincare
BATCH COST
€30K
REVENUE
€47.5K
Paid back in 4.5 months
1.58× return on investment
1,232 unique buyers
Run-rate: €5.2K/mo HT
Sérum Lèvres
Launched Dec 2025 · Skincare
BATCH COST
€20K
REVENUE
€22.5K
Paid back in 4 months
885 unique buyers
1.13× return on investment
Run-rate: €5.0K/mo HT
Crayons 3-en-1
Launched Feb 2026 · Colour + Care
BATCH COST
€27K
REVENUE
€34.4K
1.27× ROI · Fastest payback
20× markup · 70% of revenue B2B
#1 B2B product by revenue
Run-rate: €7.3K/mo HT ↑
€77K invested → €104.4K returned · 1.36× overall ROI · Run-rate €17.5K/month · All launches profitable
04 — PRODUCT MIX TRANSFORMATION

18 months of transformation.
From V0.1 makeup to a high-recurrence model.

SEPTEMBER 2024
Before mascara launch
Makeup V0.1 73%
15%
● Makeup V0.1 73% ● Mascara 5% ● Skincare 15% ● Pencils 7%
Classic makeup = 78% of revenue
→
MARCH 2026
18 months later
V0.1 22%
Masc. 18%
Skincare 31%
Pencils 28%
● Makeup V0.1 22% ↓51pts ● Mascara 18% ↑13pts ● Skincare 31% ↑16pts ● Pencils 28% ↑21pts
Skincare + Pencils = 59% of revenue (was 22%)
MAKEUP V0.1
73% → 22%
Progressive phase-out
MASCARA + SKINCARE
20% → 49%
Strong repeat · 1–3×/yr
PENCILS
7% → 28%
20× markup · #1 B2B
NEXT 2 LAUNCHES — ACCELERATING THE TRANSITION
MAY 2026 TACTICAL LAUNCH
Regenerating Hand Balm
Quick win · Strong repeat (2×/yr) · Low batch cost · Tests the regenerative positioning before supplements.
JUNE / JULY 2026 STRATEGIC LAUNCH
Eye Patches
Strong repeat (2–3×/yr) · High Instagram/UGC potential · Bridge between skincare and supplements · Builds the repeat habit.
05 — B2B GROSS MARGIN

+14.5 points of B2B gross margin in 6 months

From 53% (Q4 2025) to 67.5% (Mar 2026) — a record — driven by 3-in-1 pencil launch, new B2B bestsellers at 20× markup and low cash intensity.

34%
Q1 25
60%
Q2 25
44%
Q3 25
53%
Q4 25
66%
Q1 26
67.5%
Mar 26
What drove it
3-in-1 pencils at 20× markup — new B2B bestsellers with low cash intensity. Single product responsible for +12pts margin gain in Q1 2026.
Avec les compléments
Target supplement margin: 75-80% B2B. Launch would push blended margin toward >70% across the entire B2B catalogue.
ECLO 2.0

À partir de juillet 2026.

06 — THE SUPPLEMENT OPPORTUNITY

Beauty supplements,
the new well-ageing imperative.

€3B
French supplement market 2025
+9% total +25% online
61%
French adults take supplements
+102%
Collagen growth in pharmacy — the category is exploding
We have entered a new era of aging and self-care. The glow-up comes from supporting the systems that keep the body vibrant, and alive.
Longevity starts from within. After 40, the body needs cellular support. This is the positioning Eclo 2.0 was built for.
07 — THE MODEL & EXITS

A model with very high recurrence.
The big players have noticed.

WHY SUPPLEMENTS
Purchase frequency4–12×/year
Subscription rateup to 80–90%
DTC gross margin75–85%
CAC payback1–2 months
Customer LTV (3Y)€800–1,500+
RECENT EXITS
Nutrafol
Unilever 2022 · Revenue doubled post-acq.
$800M
Vital Proteins
Nestlé 2021 · Collagen · ~$250M rev.
$500M+
Nutripure 🇫🇷
PAI Partners 2024 · €1M→€40M · +90%/yr
majority
Europe is 5 years behind the US. Pharma brands dominate but lack beauty credibility. DTC beauty brands haven't leapt. Nobody has done it for beauty yet.
08 — CUSTOMER VALIDATION

Our customers already buy supplements.

We surveyed our customers. The market is already inside our base.

72%
Already buy supplements
From other brands. Capturing existing spend.
90%
Buy for clean ingredients
Same purchase driver. No repositioning.
74%
Indications covered
Looking for one or more indications covered by our supplement range.
74%
Trust ingredient science
Trust transfer already done.
51%
Revenue is already recurring
+934% in 3 years. Repeat is already the engine.
10K+
Addressable DTC customers
Captive base. Zero incremental CAC to launch.
09 — OUR PRODUCT STRATEGY

Innovation. Regeneration. Rituals.

01 — Classic brands repair skin. Eclo regenerates the terrain.

Cellular energy, inflammatory balance, hormonal and nervous terrain. No French brand has taken this territory.

02 — Complete formulas, built as systems.

8 months of formulation. Patented actives — ExceptionHYAL®star, Reggenerate®, SkinAx2™, Kaneka CoQ10, Ceramosides® Seppic, Albion®. Formulas designed as protocols.

03 — Innovative, non-animal, clinically superior sources.

Eggshell membrane collagen — vegetarian, biosourced, upcycled. 100% algae Omega 3 — no fish, no odor, optimized DHA/EPA ratio (500mg DHA / 100mg EPA). Natural and performance are no longer opposed.

04 — Designed to be taken. Really.

Two capsules per day. No taste. No odor. Adherence is problem #1 — we built it in from the start. A product taken daily is worth infinitely more than one that's forgotten.
10 — THE PRODUCT SYSTEM

Not just a lineup of products.
Real protocols and loyalty programs.

2 HERO PRODUCTS
HydraGlow — €42
Hydration · Skin barrier · Glow — 25–40 ans
Fermeté & Well-Ageing — €45
Anti-aging · Firmness · Cellular energy — 40+
3 MONO-INGREDIENTS & UNIVERSAL BASE
Hyalu Boost — €25
Entry-level · Essential hydration
Complexe Collagène — €25
Entry-level · Essential firmness
Omega Glow — €28
Universal base · Inflammation, energy, mood. In every protocol.
THE 6 PROTOCOLS
01 — Découverte Hydra
Hyalu Boost + Omega Glow — 25–35 yrs — €53/mo
02 — Découverte Anti-âge
Complexe Collagène + Omega Glow — 40+ — €53/mo
03 — Essentiel Hydra
HydraGlow + Omega Glow — 25–40 yrs — €70/mo
04 — Transition
HydraGlow + Complexe Collagène + Omega Glow — 38–45 yrs — €95/mo
05 — Intensif Anti-âge
Fermeté & Well-Ageing + Omega Glow — 40+ — €73/mo
06 — Régénératif Complet
HydraGlow + Fermeté + Omega Glow — 40+ — €115/mo
5 produits · 6 protocoles · €115/mo max
11 — PROTOCOL ECONOMICS

The economics of protocols.
The power of recurrence.

75%
Gross margin — HydraGlow
€42 TTC
78%
Gross margin — Fermeté & Well-Ageing
€45 TTC
79–82%
Gross margin — Mono-ingredients & Omega Glow
MONTHLY BASKET & LTV PER PROTOCOL (3-MONTH CURE)
PROTOCOL
TARGET
BASKET/MO
LTV 3 MONTHS
01 — Découverte Hydra
25–35 yrs
€53
€159
02 — Découverte Anti-âge
40+
€53
€159
03 — Essentiel Hydra
25–40 yrs
€70
€210
04 — Transition
38–45 yrs
€95
€285
05 — Intensif Anti-âge
40+
€73
€219
06 — Régénératif Complet
40+
€115/mo
€345 / 3 mois
Supplement repeat: 6×+ per year per SKU. Highest LTV, highest margin in the Eclo catalogue.
12 — ROADMAP 2026

A 2026 launch roadmap in 3 waves.
Each wave builds on the previous.

JULY 2026

Heroes + Mono-ingredients

HydraGlow · Fermeté · Hyalu Boost · Complexe Collagène

4 protocols. First sales on existing customer base.

SEPTEMBER 2026

Universal base + Full protocols

Omega Glow added. All 6 protocols live.

100-store retail activation. 3-month subscription cures.

NOVEMBER 2026

New skincare segments

Inflammation Fighter · Clear Skin+ · AOX Radiance+

8 products total. Repeat maximized.

13 — SUPERCHARGING REPEAT PURCHASES

A new engine enabling rapid acquisition scaling.

Today, on skincare + makeup, Eclo acquires a customer and waits 6–12 months before a potential reorder. Supplements completely invert this dynamic.

TODAY · SKINCARE
6–12 mo
Before 2nd purchase
Long payback = limited spend
WITH SUPPLEMENTS
~60 days
CAC payback on 1st order
Additional profit within 60 days
YEAR 1 ON PROTOCOL
6–12 orders
€636–1,380 revenue
75–82% gross margin
Skincare: Spend 25€ to acquire → wait 6–12 months → maybe 57€ back. Hard to scale.
Supplements: Spend 25€ → 70€ month 1, 70€ month 2, 70€ month 3. CAC recovered on 1st order.
Full protocol: 115€/mo × 12 = 1,380€/year at 77% margin. LTV:CAC of 30:1+.
13b — NET MARGIN BY MODEL

What each customer actually generates,
after all costs.

25€ CAC (order 1 only). 7€ logistics/order. COGS 22–35% depending on product.

YEAR 1
Eclo 0.1 · Makeup+1€
Eclo 0.2 · + Skincare+15€
Eclo 0.3 · + Supplements+79€
Includes 25€ CAC on 1st order
YEAR 2 CUMULATIVE
Eclo 0.1+1€
Eclo 0.2+20€
Eclo 0.3+154€
Zero CAC in year 2 · Pure margin
YEAR 3 CUMULATIVE
Eclo 0.1+2€
Eclo 0.2+24€
Eclo 0.3+229€
115× more net margin than makeup alone
Net margin = Revenue − COGS − logistics (7€/order) − CAC (25€, order 1 only, year 1 only). Eclo 0.3: Y2/Y3 = 4 orders × 105€, zero CAC.
14 — PROJECTIONS

Eclo 2026–2027–2028

2026
€800K
Net revenue HT
● LFL 66% ● Supplements 30%
Gross margin
€572K 71.6%
EBITDA
~€0 breakeven
2027
€2.1M
Net revenue HT · ×2.7
● LFL 28% ● Supplements 70%
Gross margin
€1.56M 73.4%
EBITDA
€272K 12.8%
2028
€5M+
Net revenue HT · ×2.5
● Supplements >85%
Gross margin
€3.75–4.5M ~75%
EBITDA
€0.75–1.2M 15–20%
Internal projections. 2028 based on acquisition scaling + retail distribution + supplement repeat. EBITDA 2028 = contribution margin after all operating costs.
15 — THE TEAM
Julien Callede
CO-FOUNDER
Co-founder of Made.com (0→£450M revenue, IPO 2021). COO for 7 years — operations, supply chain, European expansion.
HEC Paris. Board Decathlon Performance Sports. First shareholder and non-exec Healf.com, NextMomentum. Pre-seed investor.
Marine Archer
CEO
Former CMO Nutripure (€1M→€40M, +90%/yr, PAI Partners exit 2024). 15 years in skincare and beauty.
ESSEC. Marketing Director NAOS/Bioderma. International marketing LATAM & Middle East.

Thank you.

hello@eclobeauty.com